CM-101

( DrugBank: CM-101 / KEGG DRUG: - )


2 diseases
IDDisease name (Link within this page)Number of trials
51Scleroderma2
IDDisease name (Link within this page)Number of trials
94Primary sclerosing cholangitis5

51. Scleroderma


Clinical trials : 639Drugs : 551 - (DrugBank : 157) / Drug target genes : 135 - Drug target pathways : 222 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

94. Primary sclerosing cholangitis


Clinical trials : 177Drugs : 120 - (DrugBank : 48) / Drug target genes : 25 - Drug target pathways : 148 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries